Back
ESC2025 Premium Access

Comprehensive cardiovascular magnetic resonance for evaluating structural myocardial changes in patients with hypertrophic obstructive cardiomyopathy treated with the first myosin inhibitor

Session: Prognostic imaging in hypertrophic cardiomyopathy and amyloidosis
Topic: Myocardial Disease
Speaker: Doctor L. Seuthe (Cologne, DE)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Leni Katharina Seuthe

Cologne University Hospital - Heart Center, Cologne (Germany)
1 presentation
0 follower

5 more presentations in this session

Assessment of left ventricular function measured with cardiac MRI feature tracking predicts heart failure events in childhood hypertrophic cardiomyopathy

Speaker: Doctor X. Chen (Beijing, CN)

Access
Abstract
Slides
Like
Thumbnail

CMR-based assessment of left ventricular hemodynamics in obstructive hypertrophic cardiomyopathy treated with septal reduction therapy

Speaker: Ms M. Yu (Sichuan, CN)

Access
Abstract
Slides
Like
Thumbnail

The PA/Ao ratio as a predictor for adverse outcomes in light-chain vs. transthyretin cardiac amyloidosis

Speaker: Mr L. List (Vienna, AT)

Access
Abstract
Slides
Like
Thumbnail

Novel thresholds for all-cause mortality risk stratification in hypertrophic cardiomyopathy using cardiac magnetic resonance- late gadolinium enhancement

Speaker: Miss S. Arshanapalli (London, GB)

Access
Abstract
Slides
Like
Thumbnail

Cardiovascular magnetic resonance late gadolinium enhancement risk score for mortality in hypertrophic cardiomyopathy: the HCM-LGE risk score

Speaker: Doctor J. Florence (Paris, FR)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Prognostic imaging in hypertrophic cardiomyopathy and amyloidosis

Speakers: Doctor L. Seuthe, Doctor X. Chen, Ms M. Yu, Mr L. List, Miss S. Arshanapalli...
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources